| Literature DB >> 33312867 |
Nukun Puisungnoen1, Aranya Yantapant1, Marut Yanaranop1.
Abstract
OBJECTIVES: The aim of this study is to evaluate the safety and efficacy of natural orifice transluminal endoscopic surgery-assisted vaginal hysterectomy (NOTES-AVH) compared with total laparoscopic hysterectomy (TLH).Entities:
Keywords: Hysterectomy; laparoscopy; natural orifice transluminal endoscopic surgery; vaginal surgery
Year: 2020 PMID: 33312867 PMCID: PMC7713652 DOI: 10.4103/GMIT.GMIT_130_19
Source DB: PubMed Journal: Gynecol Minim Invasive Ther ISSN: 2213-3070
Baseline characteristics of patients of the entire cohort
| Characteristics | NOTES-H ( | TLH ( | |
|---|---|---|---|
| Age (years) | 47.3±6.7 | 45.3±5.5 | 0.034 |
| Body mass index (kg/m2) | 24.7±4.4 | 24.6±4.1 | 0.849 |
| Nulliparity | |||
| Parity | 17 (34.0) | 73 (41.0) | 0.370 |
| Currently sexually active | 41 (82.0) | 136 (76.4) | 0.674 |
| Presence of underlying disease | 12 (24.0) | 48 (27.0) | 0.647 |
| Previous abdominal surgery | 18 (36.0) | 66 (37.1) | 0.135 |
| Preoperative diagnosis | |||
| Myoma uteri | 24 (48.0) | 80 (44.9) | 0.178 |
| Adenomyosis | 19 (38.0) | 86 (48.3) | |
| Others | 7 (14.0) | 12 (6.8) | |
| Presence of endometriosis | 1 (2.0) | 43 (24.2) | <0.001 |
| Uterine weight (g), median (IQR) | 159.0 (138) | 231.5 (240.2) | 0.009 |
Data are present as number (percentage) or mean±SD unless stated otherwise. NOTES-AVH: Natural orifice transluminal endoscopic surgery-assisted vaginal hysterectomy, TLH: Total laparoscopic hysterectomy, IQR: Interquartile range, SD: Standard deviation
Characteristics of patients after a propensity score matching
| Characteristics | NOTES-H ( | TLH ( | |
|---|---|---|---|
| Age (years) | 47.3±6.7 | 48.2±5.8 | 0.455 |
| Body mass index (kg/m2) | 24.7±4.4 | 24.5±4.2 | 0.754 |
| Nulliparity | 17 (34.0) | 20 (40.0) | 0.534 |
| Currently sexually active | 41 (82.0) | 40 (80.0) | 0.799 |
| Presence of underlying disease | 12 (24.0) | 12 (24.0) | 1.000 |
| Previous abdominal surgery | 18 (36.0) | 20 (40.0) | 0.916 |
| Preoperative diagnosis‡ | |||
| Myomauteri | 24 (48.0) | 23 (46.0) | 0.977 |
| Adenomyosis | 19 (38.0) | 20 (40.0) | |
| Others | 7 (14.0) | 7 (14.0) | |
| Presence of endometriosis§ | 1 (2.0) | 1 (2.0) | 1.000 |
Data are present as number (percentage) or mean±SD. NOTES-AVH: Natural orifice transluminal endoscopic surgery- assisted vaginal hysterectomy, TLH: Total laparoscopic hysterectomy, SD: Standard deviation
Perioperative outcomes cross-tabulated by the type of surgical approach after a propensity score matching
| Outcomes | NOTES-AVH ( | TLH ( | Relative measures (95% CI) |
|---|---|---|---|
| Operative time (min) | 146.0±57.9 | 161.9±68.8 | MD: 15.9 (−9.3-41.1) |
| EBL (mL), median (IQR) | 300 (450) | 100 (212.5) | NA |
| Packed red cell transfusion | 3 (6.0) | 2 (4.0) | RR: 1.50 (0.26-8.60) |
| Intraoperative complications | 1 (2.0)* | 3 (6.0)** | RR: 0.33 (0.04-3.10) |
| VAS of pain at 6-h after operation | 3.4±1.8 | 4.9±1.8 | MD: 1.5 (0.8-2.2) |
| VAS of pain at 24-h after operation | 1.7±1.5 | 2.7±1.5 | MD: 1.0 (0.4-1.6) |
| Morphine consumption (mg), median (IQR) | 0.0 (3.0) | 0.0 (3.0) | NA |
| Postoperative fever | 9 (18.0) | 13. (26.0) | RR: 0.69 (0.33-1.47) |
| Length of hospital stay (days) | 2.5±0.8 | 2.8±0.8 | MD: 0.3 (0.1-0.7) |
*Massive blood loss, **Including conversion to laparotomy (1); bowel injury (1); and urologic injury (1). Data are present as number (percentage) or mean±SD unless stated otherwise. NOTES-AVH: Natural orifice transluminal endoscopic surgery-assisted vaginal hysterectomy, TLH: Total laparoscopic hysterectomy, MD: Mean difference, RR: Risk ratio, CI: Confidence interval, EBL: Estimated blood loss, NA: Not assessed, IQR: Interquartile range, VAS: Visual analog scale, SD: Standard deviation